IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,663,260 | +12.2% | 36,668 | +1.5% | 0.01% | +16.7% |
| Q2 2023 | $1,482,742 | +12.0% | 36,138 | -2.4% | 0.01% | 0.0% |
| Q1 2023 | $1,323,917 | -2.8% | 37,043 | +2.8% | 0.01% | -7.7% |
| Q4 2022 | $1,361,495 | -11.2% | 36,047 | +3.9% | 0.01% | -18.8% |
| Q3 2022 | $1,534,000 | +20.3% | 34,680 | +0.7% | 0.02% | +33.3% |
| Q2 2022 | $1,275,000 | +0.2% | 34,441 | +0.3% | 0.01% | +20.0% |
| Q1 2022 | $1,272,000 | +22.3% | 34,354 | +0.5% | 0.01% | +25.0% |
| Q4 2021 | $1,040,000 | -10.3% | 34,190 | -1.1% | 0.01% | -11.1% |
| Q3 2021 | $1,159,000 | -15.7% | 34,557 | +0.3% | 0.01% | -18.2% |
| Q2 2021 | $1,375,000 | -20.2% | 34,461 | -10.0% | 0.01% | -26.7% |
| Q1 2021 | $1,722,000 | -20.0% | 38,299 | +0.6% | 0.02% | -25.0% |
| Q4 2020 | $2,152,000 | +12.6% | 38,055 | -5.5% | 0.02% | +5.3% |
| Q3 2020 | $1,911,000 | +4.1% | 40,274 | +29.4% | 0.02% | -26.9% |
| Q2 2020 | $1,835,000 | +26.2% | 31,127 | +1.2% | 0.03% | +4.0% |
| Q1 2020 | $1,454,000 | – | 30,752 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |